ACE2 and prognosis of COVID‐19: Insights from Bartter's and Gitelman's syndromes patients

Documenti analoghi

• ACE2 and SARS-CoV-2 Infection Risk: Insights From Patients With Two Rare Genetic Tubulopathies, Gitelman's and Bartter's Syndromes
  di: Calò, Lorenzo A., et al.
  Pubblicazione: (2021)
• MO012 ACE2 AND SARS-COV-2 INFECTION RISK: INSIGHTS FROM PATIENTS WITH TWO RARE GENETIC TUBULOPATHIES, GITELMAN‘S AND BARTTER’S SYNDROMES
  di: Bertoldi, Giovanni, et al.
  Pubblicazione: (2021)
• Far di Necessità Virtù, using rare tubulopathies, Gitelman’s and Bartter’s syndromes, to inform the fight against COVID-19
  di: Calò, Lorenzo A., et al.
  Pubblicazione: (2021)
• Are the Clinical Presentations (Phenotypes) of Gitelman’s and Bartter’s Syndromes Gene Mutations Driven by Their Effects on Intracellular pH, Their “pH” Enotype?
  di: Calò, Lorenzo A, et al.
  Pubblicazione: (2020)
• Rho kinase inhibitors for SARS-CoV-2 induced acute respiratory distress syndrome: Support from Bartter’s and Gitelman’s syndrome patients
  di: Calò, Lorenzo A., et al.
  Pubblicazione: (2020)